The Effect of Unrelated Donor Marrow Transplantation on Health-Related Quality of Life: A Report of the Unrelated Donor Marrow Transplantation Trial (T-Cell Depletion Trial)

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 6, 2006, Pages 648-655

  Altmaier, Elizabeth M ^a   Ewell, Marian ^b   McQuellon, Richard ^c   Geller, Nancy ^d   Carter, Shelly L ^b   Henslee Downey, Jean ^e   Davies, Stella ^f   Papadopoulos, Esperanza ^g   Yanovich, Saul ^h   Gingrich, Roger ⁱ  

^a UNIVERSITY OF IOWA   (United States)

^b EMMES CORPORATION   (United States)

^c WAKE FOREST BAPTIST HEALTH   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e UNIVERSITY OF SOUTH CAROLINA   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Bone marrow transplantation; Quality of life; T cell depletion

Indexed keywords

ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; METHOTREXATE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CANCER THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DATA ANALYSIS; DEPRESSION; DONOR; EX VIVO STUDY; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NORMAL VALUE; OUTCOME ASSESSMENT; POPULATION RESEARCH; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SHORT FORM 36; T CELL DEPLETION; TREATMENT OUTCOME; UNITED STATES;

ADULT; BONE MARROW TRANSPLANTATION; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERVIEWS; LYMPHOCYTE DEPLETION; QUALITY OF LIFE; T-LYMPHOCYTES; TIME FACTORS; TISSUE DONORS;

EID: 33646760626     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.01.003     Document Type: Article

References (25)

1. Hale G., Zhang M., Bunjes D., et al. Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host-disease and graft rejection. Blood 92 (1998) 4581-4590
2. Soiffer R.J., Weller E., Alyea E.P., et al. CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors. J Clin Oncol 19 (2001) 1152-1159
3. Ho V.T., Weller E., Lee S.J., et al. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7 (2001) 223-229
4. Moscardó F., Sanz G.F., de la Rubia J., et al. Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34+ positive selection. Bone Marrow Transplant 27 (2001) 983-988
5. Kernan N.A., Bartsch G., Ash R.C., et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328 (1993) 593-602
6. Andrykowski M.A., and McQuellon R.P. Psychosocial issues in hematopoietic stem cell transplantation. In: Blume K.G., Forman S.J., and Appelbaum F. (Eds). Thomas' Hematopoietic Cell Transplantation. 3rd ed. (2003), Blackwell, Oxford, UK 497-506
7. Wagner J.E., Thompson J.S., Carter S., and Kernan N. Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial). a multi-centre, randomised phase II-III trial. Lancet 366 (2005) 733-741
8. Aaronson N.K. Assessment of quality of life and benefits from adjuvant therapies in breast cancer. Recent Results Cancer Res 127 (1993) 201-210
9. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30. a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
10. Gotay C.C., Korn E.L., McCabe M.S., et al. Quality-of-life assessment in cancer treatment protocols. research issues in protocol development. J Natl Cancer Inst 84 (1992) 575-579
11. Cella D.F., and Bonomi A.E. Measuring quality of life. 1995 update. [review]. Oncology (Huntingt) 9 11 suppl (1995) 47-60
12. Cella D.F. Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System, Version 4 (1997), Center on Outcomes, Research and Education (CORE), Evanston Northwestern Healthcare and Northwestern University, Evanston, IL
13. McQuellon R.P., Russell G.B., Cella D.F., et al. Quality of life measurement in bone marrow transplantation. development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplantation (FACT-BMT) scale. Bone Marrow Transplant 19 (1997) 357-368
14. Ware J.E., Kosinski M., and Keller S.D. SF-36 Physical and Mental Healthy Summary Scales. A User's Manual (1994), The Health Institute, Boston
15. Radloff L.S. The CES-D scale. a self-report depression scale for research in the general population. Appl Psychol Meas 1 (1977) 385-401
16. Brucker P.S., Yost K., Cashy J., Webster K., and Cella D. General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof 28 (2005) 192-211
17. Cornish J.M., Pamphilon D.H., Potter M.N., et al. Unrelated donor bone marrow transplant in childhood ALL. the role of T-cell depletion. Bone Marrow Transplant 18 suppl 2 (1999) 31-35
18. Schimmer A.D., Elliott M.E., Abbey S.E., et al. Illness-intrusiveness among survivors of autologous blood and marrow transplantation. Cancer 92 (2001) 3147-3154
19. Andrykowski M.A., Brady M.J., Greiner C.B., et al. 'Returning to normal' following bone marrow transplantation. outcomes, expectations and informed consent. Bone Marrow Transplant 15 (1995) 573-581
20. Chiodi S., Spinelli S., Ravera G., et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol 110 (2000) 614-619
21. Yano K., Kanie T., Okamoto S., et al. Quality of life in adult patients after stem cell transplantation. Int J Hematol 71 (2000) 283-289
22. Andrykowski M.A., Bishop M.M., Hahn E.A., et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol 23 (2005) 599-608
23. Bush N.E., Donaldson G.W., Haberman M.H., et al. Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation. a longitudinal follow up of 415 patients. Biol Blood Marrow Transplant 6 (2000) 576-591
24. Lee S.J., Zahrieh D., Alyea E.P., et al. Comparison of T-cell depleted and non-T-cell depleted unrelated donor transplantation for hematologic diseases. clinical outcomes, quality of life, and costs. Blood 100 (2002) 2697-2702
25. McQuellon R.P., Russell G.R., Rambo T.D., et al. Quality of life and psychological distress of bone marrow transplant recipients. the "time trajectory" to recovery over the first year. Bone Marrow Transplant 21 (1998) 477-486